Skip to Content
Merck

Progress in understanding 2-hydroxyglutaric acidurias.

Journal of inherited metabolic disease (2012-03-07)
Martijn Kranendijk, Eduard A Struys, Gajja S Salomons, Marjo S Van der Knaap, Cornelis Jakobs
ABSTRACT

The organic acidurias D: -2-hydroxyglutaric aciduria (D-2-HGA), L-2-hydroxyglutaric aciduria (L-2-HGA), and combined D,L-2-hydroxyglutaric aciduria (D,L-2-HGA) cause neurological impairment at young age. Accumulation of D-2-hydroxyglutarate (D-2-HG) and/or L-2-hydroxyglutarate (L-2-HG) in body fluids are the biochemical hallmarks of these disorders. The current review describes the knowledge gathered on 2-hydroxyglutaric acidurias (2-HGA), since the description of the first patients in 1980. We report on the clinical, genetic, enzymatic and metabolic characterization of D-2-HGA type I, D-2-HGA type II, L-2-HGA and D,L-2-HGA, whereas for D-2-HGA type I and type II novel clinical information is presented which was derived from questionnaires.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
D-α-Hydroxyglutaric acid disodium salt, ≥98.0% (GC)